<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disorder</z:e> characterized by the occurrence of cerebrovascular disease associated with <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is the most frequent type of acquired <z:hpo ids='HP_0100724'>thrombophilia</z:hpo>, defined by the occurrence of <z:mp ids='MP_0005048'>thrombosis</z:mp> or pregnancy morbidity in the presence of persistently positive <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Approximately 80% of <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> patients have an <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> marker </plain></SENT>
<SENT sid="3" pm="."><plain>These antibodies may play a pathogenetic role in some cases of <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e>, and many authors consider these two syndromes as the same entity </plain></SENT>
<SENT sid="4" pm="."><plain>Although clinical features of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> may overlap, there is a distinction between clinical and laboratory evidence suggesting that these two entities are different diseases </plain></SENT>
<SENT sid="5" pm="."><plain>A recent finding of <z:hpo ids='HP_0003256'>coagulopathies</z:hpo>, including elevated levels of coagulation factor VII, decreased levels of protein S, and activated protein C in <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> patients suggested a possible biological link between the vasculopathy and a primary <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, the clinical course seems to be progressive in <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> patients and includes increase of disability and <z:e sem="disease" ids="C0854193" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive deterioration</z:e>, more arterial involvement, and the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> shows a more benign course </plain></SENT>
<SENT sid="7" pm="."><plain>Both syndromes share clinical and laboratory features, and whether <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> represents a spectrum of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> remains unclear </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> patients have a worse prognosis and may represent a subgroup of patients who demands more rigorous follow-up </plain></SENT>
<SENT sid="9" pm="."><plain>It is important to recognize the <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e>, particularly because <z:hpo ids='HP_0001297'>stroke</z:hpo> episodes may be prevented through appropriate treatment </plain></SENT>
</text></document>